Naturally occurring p16Ink4a-positive cells shorten healthy lifespan
Open accessThe DOI matches its Crossref record; 51 of the 51 references it cites were found in a registry or an index; 21 of the 42 sources its claims cite were checked for support.
Abstract
Cellular senescence, a stress-induced irreversible growth arrest often characterized by expression of p16(Ink4a) (encoded by the Ink4a/Arf locus, also known as Cdkn2a) and a distinctive secretory phenotype, prevents the proliferation of preneoplastic cells and has beneficial roles in tissue remodelling during embryogenesis and wound healing. Senescent cells accumulate in various tissues and organs over time, and have been speculated to have a role in ageing. To explore the physiological relevance and consequences of naturally occurring senescent cells, here we use a previously established transgene, INK-ATTAC, to induce apoptosis in p16(Ink4a)-expressing cells of wild-type mice by injection of AP20187 twice a week starting at one year of age. We show that compared to vehicle alone, AP20187 treatment extended median lifespan in both male and female mice of two distinct genetic backgrounds. The clearance of p16(Ink4a)-positive cells delayed tumorigenesis and attenuated age-related deterioration of several organs without apparent side effects, including kidney, heart and fat, where clearance preserved the functionality of glomeruli, cardio-protective KATP channels and adipocytes, respectively. Thus, p16(Ink4a)-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs, and their therapeutic removal may be an attractive approach to extend healthy lifespan.
Overview
CoChat Summary
TL;DR
Clearance of naturally occurring p16Ink4a-positive senescent cells in non-progeroid INK-ATTAC mice starting at 12 months of age extended median lifespan and delayed multiple age-related pathologies. The authors conclude that p16Ink4a-positive cells that accumulate during adulthood negatively influence lifespan and promote age-dependent changes in several organs.
Key findings
- AP20187 treatment extended median lifespan in both sexes and two genetic backgrounds: mixed-background mice by 27% and C57BL/6 mice by 24% when sexes were combined; sex-specific median lifespan increases ranged from 17% to 35%. Maximum lifespan was significantly increased only for mixed AP-treated males and females combined (p = 0.0295), not for C57BL/6 mice or individual sexes.
- Clearance delayed tumorigenesis and increased tumor latency without changing the incidence or spectrum of macroscopically detectable tumors at autopsy; median lifespan extension among AP-treated mice dying without tumors ranged from 24% to 42%.
- Clearance attenuated age-related deterioration in fat, kidney, heart, and eye: it prevented fat mass loss and adipogenesis marker declines, reduced glomerulosclerosis and blood urea nitrogen increases, reduced cardiomyocyte hypertrophy and preserved cardiac stress tolerance, and delayed cataract formation. It also prevented age-dependent reductions in spontaneous activity and exploratory behavior.
- Clearance was partial and tissue selective: p16Ink4a-positive cells were reduced in most tissues examined but not colon or liver. In iWAT, AP-treated mice had 8-fold fewer GFP+ adipocyte progenitors; X-Gal crystal-containing cells were 0.2% vs 1.6% in iWAT and 0.3% vs 1.2% in kidney for AP-treated vs untreated mice, respectively.
Methods
- Two consecutive cohorts of INK-ATTAC transgenic mice were injected twice weekly with AP20187 or vehicle beginning at 12 months of age until moribund or death. The first cohort was on a mixed 129Sv × C57BL/6J × FVB background fed a 9% fat diet; the second was on a congenic C57BL/6J background fed a 5% fat diet. Dosing was 0.2 μg AP20187/g body weight between 12 and 18 months and 2.0 μg/g thereafter in the mixed cohort, and 2.0 μg/g from 12 months in the C57BL/6J cohort.
- Lifespan was analyzed with survival curves and log-rank tests; maximum lifespan was tested with two-sided Wang-Allison tests. Healthspan analyses at 18 months included qRT-PCR for senescence and inflammation markers, FACS, SAβ-Gal staining, TEM with X-ray elemental analysis, echocardiography, cardiac stress tests, metabolic and behavioral assays, and histology.
- The paper states that no power calculations were used; sample sizes were based on previously published experiments where differences were observed. Investigators were blinded to allocation during experiments and outcome assessment except for rare instances where blinding was not possible.
Limitations
- The authors state that clearance was partial and several key tissues were refractory, including liver and colon; they note that further optimization of senescent cell removal protocols is needed.
- The authors state that repetitive vehicle injection stress may have negatively impacted longevity of male C57BL/6 mice, and that maximum lifespan was not extended in C57BL/6 AP-treated animals.
- The authors state that their limited analyses do not exclude the possibility that other p16Ink4a-positive non-senescent cells engage ATTAC and die upon AP exposure; they also note that no power calculations were used.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
8 Valid · 5 Not valid · 8 Not checked · 114 Own results and interpretations
Every source the paper cites for this claim was checked and supports it.
In the paper
“Earlier we have shown that, in BubR1 progeroid mice, ATTAC ablates p16 Ink4a -positive senescent cells upon administration of AP20187 (AP), a dimerizer that activates FKBP-fused Casp8 4 .”
What the sources say
- Supportedcites [4] 4. Baker DJ, et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature. 2011; 479:232-236. [PubMed: 22048312] source
In the main text (Fig. 3a–e), AP20187-treated BubR1H/H;INK-ATTAC mice show reduced senescence markers, which the authors interpret as clearance of senescent cells. The Methods ('Mouse strains and drug treatments') identifies AP20187 as the dimer-inducing drug, and the main text describes activation of the FKBP–Casp8 fusion protein by AP20187. (LLM, conf=0.94)
boostedstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2 , 13 (Extended Data Fig. 2h), further implying that transgene induction is quite selective for senescence.”
What the sources say
- Not checked — no full text of the sourcecites [2] 2. Sharpless NE, Sherr CJ. Forging a signature of in vivo senescence. Nat Rev Cancer. 2015; 15:397408. [PubMed: 26105537] source
- Partly supportedcites [13] 13. Liu Y, et al. Expression of p16(INK4a) in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009; 8:439-448. [PubMed: 19485966] sourceExperimental — accuracy not yet measured
The section ‘Increased p16 INK4a expression is associated with chronological age’ reports that p16 INK4a expression in peripheral blood T lymphocytes increases with age (page unavailable). It does not address ATTAC induction or establish whether those cells express multiple senescence markers, so it supports only the aging-related p16 portion of the attributed claim. (LLM, conf=0.88)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“When AP was administered during wound closure, healing was delayed with similar kinetics as 4- or 18-month-old ATTAC mice without prior AP treatment, indicating that acute senescence mechanisms are preserved with aging and not influenced by constitutive clearance of senescent cells 3 .”
What the sources say
- Could not verifycites [3] 3. van Deursen JM. The role of senescent cells in ageing. Nature. 2014; 509:439-446. [PubMed: 24848057] sourceExperimental — accuracy not yet measured
The 'Senescence in ageing and age-related disease' section says AP20187 was used to eliminate senescent cells in INK-ATTAC mice. The 'Acute versus chronic senescence' section discusses senescence during wound closure, but neither section reports AP administration during wound closure, delayed healing, or a comparison with untreated 4- or 18-month-old mice. Pages were not provided in our copy. (LLM, conf=0.76)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Consistent with a beneficial role of senescent cells only for the duration of wound repair 6 - 8 , 18-month-old AP-treated ATTAC mice repaired cutaneous wounds when drug administration was suspended during healing (Extended Data Fig. 10ac).”
What the sources say
- Could not verifycites [6] 6. Jun JI, Lau LF. The matricellular protein CCN1 induces fibroblast senescence and restricts fibrosis in cutaneous wound healing. Nat Cell Biol. 2010; 12:676-685. [PubMed: 20526329] sourceExperimental — accuracy not yet measured
The Methods (Animals and cutaneous wound healing) describe 12-week-old Ccn1 mice, and the Results report wound healing in those mice. Our copy does not report 18-month-old ATTAC mice, AP treatment, or suspension of treatment during healing. In the citing sentence, this citation appears to support the preceding background point about senescent cells in wound repair; the ATTAC observation is presented as the citing authors’ own Extended Data result. (LLM, conf=0.78)
- Could not verifycites [7] 7. Krizhanovsky V, et al. Senescence of activated stellate cells limits liver fibrosis. Cell. 2008; 134:657-667. [PubMed: 18724938] sourceExperimental — accuracy not yet measured
The Animals and Results sections describe mice studied for liver fibrosis, not AP-treated ATTAC mice or cutaneous wound repair. The Discussion suggests that senescence may be relevant to other wound-healing responses, but our copy does not report the specific wound-healing observation; I searched for cutaneous wound repair and senescence. (LLM, conf=0.78)
- Partly supportedcites [8] 8. Demaria M, et al. An Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA. Dev Cell. 2014; 31:722-733. [PubMed: 25499914] sourceExperimental — accuracy not yet measured
The Results section ('Elimination of Senescent Cells Delays Cutaneous Wound Healing'; page unavailable) reports that senescent cells facilitate cutaneous wound repair. The Experimental Procedures ('Mice'; page unavailable) describe p16-3MR mice treated with GCV, not 18-month-old ATTAC mice treated with AP. Our copy does not report wound repair after AP administration was suspended during healing. (LLM, conf=0.84)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
The cited sources that could be checked couldn’t confirm or dispute this claim.
In the paper
“Clearance had no impact on the spectrum or incidence of postmortem tumors, which is consistent with the hypothesis that senescent cells help create a tissue microenvironment that promotes tumor progression 1 .”
What the sources say
- Could not verifycites [1] 1. Campisi J. Aging, cellular senescence, and cancer. Annual review of physiology. 2013; 75:685-705. sourceExperimental — accuracy not yet measured
The Senescent Cells and Cancer section discusses how senescent cells can promote tumor growth, but it does not report whether clearing them changed the spectrum or incidence of postmortem tumors. The Immune Clearance section discusses clearance by immune cells, not postmortem tumor outcomes. Searches for postmortem tumors and tumor incidence after clearance found no passage addressing that result. (LLM, conf=0.76)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Could not verify
83 more claims
Create a free account to see all 135 claims and every source verdict.
- Probably not a substantial claim. 24
- It may state two separate claims as one. 25
- The quote only partly states this claim. 1
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“The expression of p16Ink4a is essentially undetectable in young and healthy tissues, but p16Ink4a+ cells accumulate in many aged or diseased tissues.18,19,21,22,23,28”
From Identifying specific functional roles for senescence across cell types (2024) · doi:10.1016/j.cell.2024.09.021 · cites this paper as [28]
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Ablating p16+ cells in these mice suppresses age-related disease, extending the health span of two independent strains of transgenic mice: INK-ATTAC and p16-3MR (see Supplemental Figure 1 for a description of the models) (8–10).”
From Senolytic Drugs: Reducing Senescent Cell Viability to Extend Health Span (2021) · cites this paper as [9]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“AP20187, a molecule that induces apoptosis in p16INK4a-expressing cells8”
From Local clearance of senescent cells attenuates the development of post-traumatic osteoarthritis and creates a pro-regenerative environment (2017) · cites this paper as [8]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“supporting the notion that senescent cells progressively accumulate in the organism during aging at previously described rates for mice30.”
From SenCat: Cataloging human cell senescence through multi-omic profiling of multiple senescent primary cell types (2026) · cites this paper as [30]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Glomerular endothelial cells140 and proximal tubular epithelial cells (TECs)140,141 become senescent with ageing in mice, showing increased SA-β-gal staining and Cdkn2a expression.”
From SenNet recommendations for detecting senescent cells in different tissues (2024) · cites this paper as [141]
Experimental — accuracy not yet measured
77 more claims about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Statistical analysis
“For consistency in these comparisons, the following denotes significance in all figures: * P < 0.05, ** P < 0.01 and *** P < 0.001.”
§ Extended Data
“Log-rank tests were used to determine statistical significance. *, P<0.01; ** P<0.001; ***, P<0.001.”
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Mouse strains and drug treatments
“Mice from this cohort were randomly assigned to be injected with AP20187 (B/B homodimerizer, Clontech, Mountain View, CA, USA) or vehicle twice a week beginning at 12 months of age.”
§ Mouse strains and drug treatments
“Dosing was 0.2 μg AP20817/g body weight between 12 and 18 months (the same dose as previously used for senescent cell clearance in BubR1 progeroid mice; see reference 4), and 2.0 μg AP20187/g body weight from thereon.”
Citations
Cites
Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders
Baker, D. J., Wijshake, T., Tchkonia, T., LeBrasseur, N. K., Childs, B. G., van de Sluis, B., Kirkland, J. L., & van Deursen, J. M. (2011) · Nature · doi:10.1038/nature10600 · Cited by 3,670 · cited 8×
“ATTAC MEFs were generated as previously described 4 .”
InfluentialSelf-citationAging, Cellular Senescence, and Cancer
Campisi, J. (2013) · Annual Review of Physiology · doi:10.1146/annurev-physiol-030212-183653 · Cited by 2,954
The role of senescent cells in ageing
van Deursen, J. M. (2014) · Nature · doi:10.1038/nature13193 · Cited by 2,623 · cited 2×
“All studies described using ATTAC mice were performed on transgenic line 3, which contains 13 copies of the transgene inserted into a single locus (data available upon request).”
Cellular senescence in aging and age-related disease: from mechanisms to therapy
Childs, B. G., Durik, M., Baker, D. J., & van Deursen, J. M. (2015) · Nature Medicine · doi:10.1038/nm.4000 · Cited by 2,363 · cited 1×
“…p16 Ink4a -positive cells is not associated with any overt detrimental effects raise the possibility that this approach may be useful to treat aspects of age-related functional decline, age-related diseases that involve senescent cells, or side-effects of therapies that create senescent cells 36 .”
Self-citationAn Essential Role for Senescent Cells in Optimal Wound Healing through Secretion of PDGF-AA
Demaria, M., Ohtani, N., Youssef, S. A., Rodier, F., Toussaint, W., Mitchell, J. R., Laberge, R.-M., Vijg, J., Van Steeg, H., Dollé, M. E. T., et al. (2014) · Developmental Cell · doi:10.1016/j.devcel.2014.11.012 · Cited by 2,045
Senescence of Activated Stellate Cells Limits Liver Fibrosis
Krizhanovsky, V., Yon, M., Dickins, R. A., Hearn, S., Simon, J., Miething, C., Yee, H., Zender, L., & Lowe, S. W. (2008) · Cell · doi:10.1016/j.cell.2008.09.015 · Cited by 2,027
Physiology of Local Renin-Angiotensin Systems
Paul, M., Poyan Mehr, A., & Kreutz, R. (2006) · Physiological Reviews · doi:10.1152/physrev.00036.2005 · Cited by 1,739 · cited 1×
“Angiotensin receptor blockers attenuate age-related glomerulosclerosis under normotensive conditions, which has led to the idea that overactivation of the local renin-angiotensin-aldosterone system (RAAS) drives the formation of sclerotic glomeruli 31, 32 .”
Programmed cell senescence during mammalian embryonic development
Muñoz-Espín, D., Cañamero, M., Maraver, A., Gómez-López, G., Contreras, J., Murillo-Cuesta, S., Rodríguez-Baeza, A., Varela-Nieto, I., Ruberte, J., Collado, M., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.019 · Cited by 1,428
Senescence is a developmental mechanism that contributes to embryonic growth and patterning
Storer, M., Mas, A., Robert-Moreno, A., Pecoraro, M., Ortells, M. C., Di Giacomo, V., Yosef, R., Pilpel, N., Krizhanovsky, V., Sharpe, J., et al. (2013) · Cell · doi:10.1016/j.cell.2013.10.041 · Cited by 1,186 · cited 1×
“Furthermore, recent studies showing that senescent cells have beneficial effects in injury repair and tissue remodelling 6–10 have called into question the simplistic view of senescence as only a driver of age-dependent pathologies, raising the specter that senescent cell clearance might remove…”
Forging a signature of in vivo senescence
Sharpless, N. E., & Sherr, C. J. (2015) · Nature Reviews Cancer · doi:10.1038/nrc3960 · Cited by 1,104 · cited 1×
“ATTAC was also not induced in peripheral blood T lymphocytes that robustly engage endogenous p16 Ink4a with aging without concomitant expression of multiple senescence markers 2, 13 (Extended Data Fig.”
Research works printed but not linked: 2
- 38. Baker DJ, et al. Increased expression of BubR1 protects against aneuploidy and cancer and extends healthy lifespan. Nat Cell Biol. 2012; 15:96-102. [PubMed: 23242215] · DOI · Paper page
- 48. Baker DJ, et al. BubR1 insufficiency causes early onset of aging-associated phenotypes and infertility in mice. Nature genetics. 2004; 36:744-749. [PubMed: 15208629] · DOI · Paper page
Cited by
Items 1,201–1,300 of 2,883
Apoptosis signal-regulating kinase 1 promotes inflammation in senescence and aging
Odawara, T., Yamauchi, S., & Ichijo, H. (2024) · Communications Biology · doi:10.1038/s42003-024-06386-0 · Cited by 30
Characterization of the HDAC/PI3K inhibitor CUDC-907 as a novel senolytic
Al-Mansour, F. S. H., Alraddadi, A. M., He, B., Saleh, A., Poblocka, M., Alzahrani, W., Cowley, S. M., & Macip, S. (2023) · Aging · doi:10.18632/aging.204616 · Cited by 30
Sharma, R., Diwan, B., Sharma, A., & Witkowski, J. M. (2022) · Biogerontology · doi:10.1007/s10522-022-09995-6 · Cited by 33
Senescent cells form nuclear foci that contain the 26S proteasome
Iriki, T., Iio, H., Yasuda, S., Masuta, S., Kato, M., Kosako, H., Hirayama, S., Endo, A., Ohtake, F., Kamiya, M., et al. (2023) · Cell Reports · doi:10.1016/j.celrep.2023.112880 · Cited by 30
Wei, X., Zheng, Z., Liu, M., Yang, Z., Xie, E., Lin, J., Gao, Y., Tan, R., She, Z., Ma, J., et al. (2023) · Acta Biomaterialia · doi:10.1016/j.actbio.2023.10.015 · Cited by 33
Major depression, physical health and molecular senescence markers abnormalities
Seitz‐Holland, J., Mulsant, B. H., Reynolds, C. F., Blumberger, D. M., Karp, J. F., Butters, M. A., Mendes‐Silva, A. P., Vieira, É. L. M., Tseng, G. C., Lenze, E. J., et al. (2023) · Nature Mental Health · doi:10.1038/s44220-023-00033-z · Cited by 33
Valentijn, F. A., Knoppert, S. N., Márquez‐Expósito, L., Rodrigues-Díez, R. R., Pissas, G., Tang, J., Tejedor-Santamaria, L., Broekhuizen, R., Samarakoon, R., Eleftheriadis, T., et al. (2022) · Kidney International · doi:10.1016/j.kint.2022.06.030 · Cited by 30
Chanmanee, T., Wongpun, J., Tocharus, C., Govitrapong, P., & Tocharus, J. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109703 · Cited by 28
Signaling Pathways Regulating Hematopoietic Stem Cell and Progenitor Aging
Singh, A. K., Althoff, M. J., & Cancelas, J. A. (2018) · Current Stem Cell Reports · doi:10.1007/s40778-018-0128-6 · Cited by 29
Disrupted Binding of Cystathionine γ-Lyase to p53 Promotes Endothelial Senescence
Hu, J., Leisegang, M. S., Looso, M., Drekolia, M.-K., Wittig, J., Mettner, J., Karantanou, C., Kyselova, A., Dumbović, G., Li, X., et al. (2023) · Circulation Research · doi:10.1161/circresaha.123.323084 · Cited by 31
“9,10 The development of endothelial cell–specific senolytic targeting seno-antigens could be a promising strategy for new therapies to diminish pathological vascular phenotypes associated with aging.”
BackgroundImmunotherapy and senolytics in head and neck squamous cell carcinoma: phase 2 trial results
Liu, N., Wu, J., Deng, E., Zhong, J., Wei, B., Cai, T., Xie, Z., Duan, X., Fu, S., Osei-Hwedieh, D. O., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03873-7 · Cited by 47
“Although cellular senescence drives various agerelated complications through SASP, identifying senescent immune cells in vivo remains difficult 24,51,52 .”
Self-citationSenescence-associated sialidase revealed by an activatable fluorescence-on labeling probe
Zhu, R., Wang, S., Xue, Z., Han, J., & Han, S. (2018) · Chemical Communications · doi:10.1039/c8cc07024e · Cited by 28
Shrestha, N., Chaturvedi, P., Zhu, X., Dee, M. J., George, V., Janney, C., Egan, J. O., Liu, B., Foster, M., Marsala, L. I., et al. (2023) · Aging Cell · doi:10.1111/acel.13806 · Cited by 28
“It has been shown that genetic ablation of p16+ cells in a transgenic mouse model could increase the lifespan of the mice versus their p16 wild- type counterparts (Baker et al., 2016).”
BackgroundAnthracycline-induced cardiotoxicity and cell senescence: new therapeutic option?
Seara, F. D. A. C., Kasai-Brunswick, T. H., Nascimento, J. H. M., & de Carvalho, A. C. C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04605-7 · Cited by 30
Wang, Q., Zhou, X., Zhang, P., Zhao, P., Nie, L., Ji, N., Ding, Y., & Wang, Q. (2020) · Steroids · doi:10.1016/j.steroids.2019.108570 · Cited by 29
Gil, J., & Withers, D. J. (2016) · Nature · doi:10.1038/nature16875 · Cited by 27
Sharma, R., & Padwad, Y. S. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101141 · Cited by 29
Thorin‐Trescases, N., Labbé, P., Mury, P., Lambert, M., & Thorin, É. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms222212232 · Cited by 31
Life-span Extension Drug Interventions Affect Adipose Tissue Inflammation in Aging
Mau, T., O’Brien, M., Ghosh, A. K., Miller, R. A., & Yung, R. L. (2019) · The Journals of Gerontology Series A · doi:10.1093/gerona/glz177 · Cited by 30
The role of lamin B receptor in the regulation of senescence-associated secretory phenotype (SASP)
En, A., Takauji, Y., Ayusawa, D., & Fujii, M. (2020) · Experimental Cell Research · doi:10.1016/j.yexcr.2020.111927 · Cited by 30
Accelerated lung aging and chronic obstructive pulmonary disease
Yoon, Y.-S., Jin, M., & Sin, D. D. (2019) · Expert Review of Respiratory Medicine · doi:10.1080/17476348.2019.1580576 · Cited by 27
Pal, K., Raghuram, G. V., Dsouza, J., Shinde, S., Jadhav, V., Shaikh, A., Rane, B., Tandel, H., Kondhalkar, D., Chaudhary, S., et al. (2022) · Scientific Reports · doi:10.1038/s41598-022-21388-w · Cited by 29
Endothelial dysfunction in the aging kidney
Borri, M., Jacobs, M. E., Carmeliet, P., Rabelink, T. J., & Dumas, S. J. (2025) · American Journal of Physiology-Renal Physiology · doi:10.1152/ajprenal.00287.2024 · Cited by 35
Lü, J., Sun, W., Liu, B., Zhang, J., Wang, R., Goltzman, D., & Miao, D. (2024) · International Journal of Biological Sciences · doi:10.7150/ijbs.93598 · Cited by 30
Post-GWAS functional analysis identifies CUX1 as a regulator of p16INK4a and cellular senescence
Jiang, D., Sun, W., Wu, T., Zou, M., Vasamsetti, S. B., Zhang, X., Zhao, Y., Phillippi, J. A., Sawalha, A. H., Tavakoli, S., et al. (2022) · Nature Aging · doi:10.1038/s43587-022-00177-0 · Cited by 31
Wang, D., Yin, L., Chen, R., Tan, W., Liang, L., Xiang, J., Zhang, H., Zhou, X., Deng, H., Guo, B., et al. (2023) · Frontiers in Medicine · doi:10.3389/fmed.2022.1018298 · Cited by 32
“The p16INK4A is a major inhibitor of cyclin-dependent kinase (CDK), which blocks the cell cycle through the G1 phase by inhibiting CDK4 and CDK6 (31, 33).”
BackgroundValenzuela, C. A., Quintanilla, R., Olate‐Briones, A., Venturini, W., Mancilla, D., Cayo, Á., Moore‐Carrasco, R., & Brown, N. E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20215292 · Cited by 30
Conserved epigenetic hallmarks of T cell aging during immunity and malignancy
Tian, M., Soerens, A. G., Alli, S., Kang, T. G., Vasandan, A. B., Wang, Z., Vezys, V., Kimura, S., Iacobucci, I., Baylin, S. B., et al. (2024) · Nature Aging · doi:10.1038/s43587-024-00649-5 · Cited by 35
Kawamura, Y., Oka, K., Semba, T., Takamori, M., Sugiura, Y., Yamasaki, R., Suzuki, Y., Chujo, T., Nagase, M., Oiwa, Y., et al. (2023) · The EMBO Journal · doi:10.15252/embj.2022111133 · Cited by 33
“In mice, targeted removal of senescent cells (senolysis) inhibits age-related deterioration and diseases (Baker et al , 2011, 2016), prompting clinical trials in humans (Calcinotto et al , 2019; Gasek et al , 2021); however, whether the findings in mice are generalizable remains an open question…”
p21 regulates expression of ECM components and promotes pulmonary fibrosis via CDK4 and Rb
Papismadov, N., Levi, N., Roitman, L., Agrawal, A., Ovadya, Y., Cherqui, U., Yosef, R., Akiva, H., Gal, H., & Krizhanovsky, V. (2024) · The EMBO Journal · doi:10.1038/s44318-024-00246-7 · Cited by 34
“Conversely, the accumulation of senescent cells in tissues, a process that occurs during aging, contributes to age-related pathologies, including fi brotic diseases, and shortens healthspan and lifespan (Baker et al, 2016; Ovadya et al, 2018).”
Grosse, L., & Bulavin, D. V. (2020) · Aging · doi:10.18632/aging.103492 · Cited by 27
Photobiomodulation has rejuvenating effects on aged bone marrow mesenchymal stem cells
Eroglu, B., Genova, E., Zhang, Q., Su, Y., Shi, X., Isales, C. M., & Eroğlu, A. (2021) · Scientific Reports · doi:10.1038/s41598-021-92584-3 · Cited by 34
Rolt, A., Nair, A., & Cox, L. S. (2019) · Biogerontology · doi:10.1007/s10522-019-09796-4 · Cited by 29
Triple jeopardy in ageing: COVID-19, co-morbidities and inflamm-ageing
Rea, I. M., & Alexander, H. D. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101494 · Cited by 29
c-Myb and C/EBPβ regulate OPN and other senescence-associated secretory phenotype factors
Flanagan, K. C., Alspach, E., Pazolli, E., Parajuli, S. P., Ren, Q., Arthur, L., TAPIA-CONYER, R. C., & Stewart, S. A. (2017) · Oncotarget · doi:10.18632/oncotarget.22940 · Cited by 32
Nolt, G. L., Keeble, A. R., Wen, Y., Strong, A. C., Thomas, N. T., Valentino, T. R., Brightwell, C. R., Murach, K. A., Patrizia, S., Weinstabl, H., et al. (2023) · GeroScience · doi:10.1007/s11357-023-00976-2 · Cited by 29
“Since the original publications showing beneficial effects of senescent cell deletion on lifespan and healthspan [42–44], there has been a large push to develop safe, effective senolytic agents.”
BackgroundMitochondrial-related microRNAs and their roles in cellular senescence
Luo, L., An, X., Xiao, Y., Sun, X., Li, S., Wang, Y., Sun, W., & Yu, D. (2024) · Frontiers in Physiology · doi:10.3389/fphys.2023.1279548 · Cited by 34
Aged mesenchymal stem cells and inflammation: from pathology to potential therapeutic strategies
Yang, X. F., Wang, Y., Rovella, V., Candi, E., Jia, W. P., Bernassola, F., Bove, P., Piacentini, M., Scimeca, M., Sica, G. S., et al. (2023) · Biology Direct · doi:10.1186/s13062-023-00394-6 · Cited by 34
Wicher, S. A., Roos, B. B., Teske, J. J., Fang, Y. H., Pabelick, C. M., & Prakash, Y. S. (2021) · PLoS ONE · doi:10.1371/journal.pone.0254710 · Cited by 30
Shankland, S. J., Rule, A. D., Kutz, J. N., Pippin, J. W., & Wessely, O. (2023) · Kidney360 · doi:10.34067/kid.0000000000000284 · Cited by 35
“26 These mice exhibit reduced age-associated glomerulosclerosis and reduced tissue damage of the surrounding cells.”
BackgroundSynthetic Biology: Immunotherapy by Design
Brenner, J., Cho, J. H., Wong, N. M. L., & Wong, W. W. (2018) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-062117-121147 · Cited by 29
Recent insights into the cellular and molecular determinants of aging
Ruan, L., Zhang, X., & Li, R. (2018) · Journal of Cell Science · doi:10.1242/jcs.210831 · Cited by 30
Khaidizar, F. D., Nakahata, Y., Kume, A., Sumizawa, K., Kohno, K., Matsui, T., & Bessho, Y. (2017) · Genes to Cells · doi:10.1111/gtc.12542 · Cited by 31
Metabolic regulation of immune cells in proinflammatory microenvironments and diseases during ageing
Li, P., Zhang, R., Cheng, L., Liu, J., & Chen, H. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101165 · Cited by 33
Evidence That SARS-CoV-2 Induces Lung Cell Senescence: Potential Impact on COVID-19 Lung Disease
Lipskaia, L., Maisonnasse, P., Fouillade, C., Sencio, V., Pascal, Q., Flaman, J., Born, E., Londoño‐Vallejo, A., Grand, R. L., Bernard, D., et al. (2021) · American Journal of Respiratory Cell and Molecular Biology · doi:10.1165/rcmb.2021-0205le · Cited by 30
Cholesterol biosynthetic pathway induces cellular senescence through ERRα
Ziegler, D. V., Czarnecka‐Herok, J., Vernier, M., Scholtes, C., Camprubi, C., Huna, A., Massemin, A., Griveau, A., Machon, C., Guitton, J., et al. (2024) · npj Aging · doi:10.1038/s41514-023-00128-y · Cited by 35
Mitochondrial Aging: Is There a Mitochondrial Clock?
Zorov, D. B., Popkov, V. A., Zorova, L. D., Vorobjev, I. A., Pevzner, I. B., Silachev, D. N., Zorov, S. D., Jankauskas, S. S., Babenko, V. A., & Plotnikov, E. Y. (2016) · The Journals of Gerontology Series A · doi:10.1093/gerona/glw184 · Cited by 31
Telomeres in toxicology: Occupational health
Shoeb, M., Meier, H. C. S., & Antonini, J. M. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107742 · Cited by 33
Fisetin, a potential skin rejuvenation drug that eliminates senescent cells in the dermis
Takaya, K., Asou, T., & Kishi, K. (2023) · Biogerontology · doi:10.1007/s10522-023-10064-9 · Cited by 38
“The selective removal of senescent cells in transgenic animal models delays several age-related diseases and extends the healthy and overall life span (Baker et al. 2016; Soto-Gamez and Demaria 2017).”
Revelations About Aging and Disease from Unconventional Vertebrate Model Organisms
Zhao, Y., Seluanov, A., & Gorbunova, V. A. (2021) · Annual Review of Genetics · doi:10.1146/annurev-genet-071719-021009 · Cited by 32
Translational geroscience: From invertebrate models to companion animal and human interventions
Lee, M. B., & Kaeberlein, M. R. (2018) · Translational Medicine of Aging · doi:10.1016/j.tma.2018.08.002 · Cited by 36
Zipple, M. N., Vogt, C. C., & Sheehan, M. J. (2023) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2023.105238 · Cited by 29
Yang, J., Jiang, Q., Liu, L., Peng, H., Wang, Y., Li, S., Tang, Y., Yu, J., Gan, R., & Liu, Z. (2020) · Aging · doi:10.18632/aging.104199 · Cited by 33
Microbiota-shaped neutrophil senescence regulates sexual dimorphism in bladder cancer
Zhu, Q., Zhang, G., Cao, M., Huang, H., He, D., Zang, Z., Xing, J., Zhan, M., Pei, S., Deng, X., et al. (2025) · Nature Immunology · doi:10.1038/s41590-025-02126-6 · Cited by 38
An, Y., Yu, R., Liu, H., Ge, C., & Dang, W. (2023) · GeroScience · doi:10.1007/s11357-023-00863-w · Cited by 32
Chromosomal instability and pro-inflammatory response in aging
Barroso‐Vilares, M., & Logarinho, E. (2019) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2019.111118 · Cited by 28
Autofluorescence-based sorting removes senescent cells from mesenchymal stromal cell cultures
Bertolo, A., Guerrero, J., & Stoyanov, J. V. (2020) · Scientific Reports · doi:10.1038/s41598-020-76202-2 · Cited by 30
Emerging links among Chromosome Instability (CIN), cancer, and aging
Rao, C. V., Asch, A. S., & Yamada, H. Y. (2016) · Molecular Carcinogenesis · doi:10.1002/mc.22539 · Cited by 27
Targeting p16INK4a Promotes Lipofibroblasts and Alveolar Regeneration after Early-Life Injury
Zysman, M., Baptista, B. R., Essari, L.-A., Taghizadeh, S., de Ménonville, C. T., Giffard, C., Issa, A., Franco‐Montoya, M., Breau, M., Souktani, R., et al. (2020) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201908-1573oc · Cited by 29
Su, Y., Wang, P., Shen, H., Sun, Z., Xu, C., Li, G., Tong, T., & Chen, J. (2018) · Journal of Cell Science · doi:10.1242/jcs.207217 · Cited by 24
Rejuvenating Strategies of Tissue-specific Stem Cells for Healthy Aging
Wang, M., Chen, J., Chen, F., Liu, Q., Sun, Y., Chen, Y., Yang, T., Bao, Y., & Hu, Y. (2018) · Aging and Disease · doi:10.14336/ad.2018.1119 · Cited by 27
BCL-2 proteins in senescence: beyond a simple target for senolysis?
Martin, N., Popgeorgiev, N., Ichim, G., & Bernard, D. (2023) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00594-y · Cited by 30
Targeting Senescent Tendon Stem/Progenitor Cells to Prevent or Treat Age-Related Tendon Disorders
Wang, H., Dai, G.-C., Li, Y., Chen, M., Lu, P., Zhang, Y., Mingzhang, Cao, M., & Rui, Y. (2022) · Stem Cell Reviews and Reports · doi:10.1007/s12015-022-10488-9 · Cited by 29
Oxaloacetate decarboxylase FAHD1 – a new regulator of mitochondrial function and senescence
Etemad, S., Petit, M., Weiss, A. K. H., Schrattenholz, A. S., Baraldo, G., & Jansen‐Dürr, P. (2018) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2018.07.007 · Cited by 28
Wang, Y., Xie, F., He, Z., Che, L., Chen, X., Yuan, Y., & Liu, C. (2023) · Small · doi:10.1002/smll.202304433 · Cited by 33
Senolytics: Targeting Senescent Cells for Age-Associated Diseases
Al‐Naggar, I. M., Kuchel, G. A., & Xu, M. (2020) · Current Molecular Biology Reports · doi:10.1007/s40610-020-00140-1 · Cited by 32
Xiong, Y., Huang, W., Ling, X., Zhou, S. Y., Wang, X., Li, X., & Zhou, L. (2024) · Acta Pharmacologica Sinica · doi:10.1038/s41401-024-01298-5 · Cited by 31
Counteracting Immunosenescence—Which Therapeutic Strategies Are Promising?
Hieber, C., Grabbe, S., & Bros, M. (2023) · Biomolecules · doi:10.3390/biom13071085 · Cited by 30
Chen, W., Wang, X., Wei, G., Huang, Y., Shi, Y., Li, D., Qiu, S., Zhou, B., Cao, J., Chen, M., et al. (2020) · Frontiers in Genetics · doi:10.3389/fgene.2020.00867 · Cited by 26
Kidney inflammaging is promoted by CCR2+ macrophages and tissue-derived micro-environmental factors
Lefèvre, L., Iacovoni, J. S., Martini, H., Bellière, J., Maggiorani, D., Dutaur, M., Marsal, D. J., Decaunes, P., Pizzinat, N., Mialet‐Perez, J., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03719-0 · Cited by 33
The role of cellular senescence in cardiovascular disease
Xu, C., Qiu, Z., Guo, Q., Huang, Y., Zhao, Y., & Zhao, R. (2025) · Cell Death Discovery · doi:10.1038/s41420-025-02720-5 · Cited by 38
Liu, S., Jia, X., Hao, J., Zhang, D., Yang, S., Dai, B., Mao, Y., & Li, Y. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202301798 · Cited by 33
Endothelial cell senescence: A machine learning-based meta-analysis of transcriptomic studies
Park, H. S., & Kim, S. Y. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101213 · Cited by 27
Alternative Targets to Fight Alzheimer’s Disease: Focus on Astrocytes
Valenza, M., Facchinetti, R., Menegoni, G., Steardo, L., & Scuderi, C. (2021) · Biomolecules · doi:10.3390/biom11040600 · Cited by 26
Cellular Identification and Quantification of Senescence-Associated β-Galactosidase Activity In Vivo
Childs, B. G., Bussian, T. J., & Baker, D. J. (2018) · Methods in molecular biology · doi:10.1007/978-1-4939-8931-7_4 · Cited by 29
Self-citationINK4a/ARF Expression Impairs Neurogenesis in the Brain of Irradiated Mice
Lê, O., Palacio, L., Bernier, G., Batinic̈‐Haberle, I., Hickson, G. R. X., & Beausejour, C. M. (2018) · Stem Cell Reports · doi:10.1016/j.stemcr.2018.03.025 · Cited by 27
Wang, H., Yu, Y., Li, R., Zhang, H., Chen, Z., Sun, C., & Zhuang, J. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.07.022 · Cited by 43
“The removal of senescent cells has been shown to fundamentally eliminate SASP production, thereby slowing the progression of age-related diseases 77,191 .”
Understanding and targeting senescence in kidney disease
Chanvillard, L., Mason, T., & Ferenbach, D. A. (2025) · Clinical Kidney Journal · doi:10.1093/ckj/sfaf190 · Cited by 34
“In aged mice, clearance of senescent cells using INK-ATTAC reduces glomerulosclerosis [22 ], while p16 + cell ablation in the p16-3MR model lowers serum urea levels in both aged and progeroid ( Xpd TTD/TTD ) mice [37 ].”
Adoptive NK cell therapy: a potential revolutionary approach in longevity therapeutics
Deng, X., & Terunuma, H. (2024) · Immunity & Ageing · doi:10.1186/s12979-024-00451-2 · Cited by 36
“This excessive presence of SNCs and SASPs disrupts tissue function, impacting neighboring cells and standing as a key contributor to AADs [10, 32, 33], ultimately curtailing the healthy lifespan [34].”
BackgroundLee, S. H., Yang, J.-H., Park, U., Choi, H., Kim, Y. S., Yoon, B., Han, H.-J., Kim, H.-T., Um, S., & Kim, E.-J. (2023) · Experimental & Molecular Medicine · doi:10.1038/s12276-023-01012-1 · Cited by 36
Hudson, H. R., Sun, X., & Orr, M. E. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2024.e00519 · Cited by 33
Finding Ponce de Leon’s Pill: Challenges in Screening for Anti-Aging Molecules
Kumar, S., & Lombard, D. B. (2016) · F1000Research · doi:10.12688/f1000research.7821.1 · Cited by 27
Time-resolved proteomic analyses of senescence highlight metabolic rewiring of mitochondria
Kim, J. Y., Atanassov, I., Dethloff, F., Kroczek, L., & Langer, T. (2023) · Life Science Alliance · doi:10.26508/lsa.202302127 · Cited by 25
Mapping cellular senescence networks in human diabetic foot ulcers
Yu, G., Monie, D. D., Khosla, S., Tchkonia, T., Kirkland, J. L., & Wyles, S. P. (2023) · GeroScience · doi:10.1007/s11357-023-00854-x · Cited by 27
“Early senescence may promote regeneration in early or acute wound healing [2, 22] and protect against cancer cell proliferation [16].”
Senescent Cells in Cancer: Wanted or Unwanted Citizens
Niklander, S. E., Lambert, D., & Hunter, K. D. (2021) · Cells · doi:10.3390/cells10123315 · Cited by 28
A GATA4-regulated secretory program suppresses tumors through recruitment of cytotoxic CD8 T cells
Patel, R. S., Romero, R., Watson, E. V., Liang, A. C. T., Burger, M. L., Westcott, P. M. K., Mercer, K. L., Bronson, R. T., Wooten, E. C., Bhutkar, A. J., et al. (2022) · Nature Communications · doi:10.1038/s41467-021-27731-5 · Cited by 27
Exercise, healthy ageing, and the potential role of small extracellular vesicles
McIlvenna, L. C., & Whitham, M. (2022) · The Journal of Physiology · doi:10.1113/jp282468 · Cited by 28
Wu, T., Xu, S., Chen, B., Bao, L., Ma, J., Han, W., Xu, A., Yu, K. N., Wu, L., & Chen, S. (2022) · Nanotoxicology · doi:10.1080/17435390.2022.2147460 · Cited by 26
“Meanwhile, senescent cells are more abundant in aged and diseased tissues, driving a large number of age-related pathologies including atherosclerosis and pulmonary fibrosis (Baker et al. 2016; Childs et al. 2016; Demaria et al. 2017).”
BackgroundGangliosides Contribute to Vascular Insulin Resistance
Sasaki, N., Itakura, Y., & Toyoda, M. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20081819 · Cited by 28
Bmi-1 alleviates adventitial fibroblast senescence by eliminating ROS in pulmonary hypertension
Li, K., Li, Y., Yu, Y., Ding, J., Huang, H., Chu, C., Hu, L., Yu, Y., Cao, Y. Z., Xu, P., et al. (2021) · BMC Pulmonary Medicine · doi:10.1186/s12890-021-01439-0 · Cited by 25
The secretome of senescent monocytes predicts age-related clinical outcomes in humans
Olinger, B., Banarjee, R., Dey, A. K., Tsitsipatis, D., Tanaka, T., Ram, A., Nyunt, T., Daya, G. N., Peng, Z., Shrivastava, M., et al. (2025) · Nature Aging · doi:10.1038/s43587-025-00877-3 · Cited by 37
Integrin β3 Induction Promotes Tubular Cell Senescence and Kidney Fibrosis
Shen, L., Jiang, S., Zhang, Q., Jin, B. R., Lv, D., Li, W., Zhao, M., Jiang, C., Dai, C., & Liu, Z. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.733831 · Cited by 35
Targeting Cellular Senescence with Senotherapeutics: Development of New Approaches for Skin Care
Thompson, E. L., Pitcher, L. E., Niedernhofer, L. J., & Robbins, P. D. (2021) · Plastic & Reconstructive Surgery · doi:10.1097/prs.0000000000009668 · Cited by 29
Non‐canonical ATM/MRN activities temporally define the senescence secretory program
Malaquin, N., Carrier-Leclerc, A., Martinez, A., Dessureault, M., Ghadaouia, S., Coppé, J., Nadeau, S., Cardin, G., Campisi, J., & Rodier, F. (2020) · EMBO Reports · doi:10.15252/embr.202050718 · Cited by 30
Senescent AECⅡ and the implication for idiopathic pulmonary fibrosis treatment
Zhang, T., Zhang, J., Lv, C., Li, H., & Song, X. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.1059434 · Cited by 29
“senescence can alleviate fibrosis and extend the life spans of experimental animals (Baker et al., 2016; Schafer et al., 2017; Hohmann et al., 2019; Rhinn et al., 2019; Omori et al., 2020).”
BackgroundJohnson, M. O., Bell, A., Lauing, K. L., Ladomersky, E., Zhai, L., Penco-Campillo, M., Shah, Y., Mauer, E. A., Xiu, J., Nicolaides, T. P., et al. (2023) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-23-0834 · Cited by 27
“The generation and characterization of the INK-ATTAC mouse line and their backcrossing onto the C57BL/6 genetic background was previously described (27, 35).”
MethodSelf-citationSenescence in aging and disorders of the central nervous system
Swenson, B. L., Meyer, C. F., Bussian, T. J., & Baker, D. J. (2019) · Translational Medicine of Aging · doi:10.1016/j.tma.2019.01.002 · Cited by 24
Self-citationChronic HIV Infection and Aging: Application of a Geroscience-Guided Approach
Masters, M. C., LANDAY, A. L., Robbins, P. D., Tchkonia, T., Kirkland, J. L., Kuchel, G. A., Niedernhofer, L. J., & Palella, F. J. (2022) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000002858 · Cited by 35
Metadata
- Authors
- Baker, D. J., Childs, B. G., Durik, M., Wijers, M. E., Sieben, C. J., Zhong, J., A. Saltness, R., Jeganathan, K. B., Verzosa, G. C., Pezeshki, A., Khazaie, K., Miller, J. D., & van Deursen, J. M.
- Affiliations
- Mayo Clinic (US)
- Corresponding author
- Baker, Darren J.
- van Deursen, Jan M.
- ORCID
- Venue
- Nature
- Published
- 2016-02
- Volume
- 530
- Issue
- 7589
- Pages
- 184-189
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC4845101
- OpenAlex
- W2266290735
- Cited by
- 2,876
- References
- 50
- Citations by year
- 2026: 254 · 2025: 253 · 2024: 318 · 2023: 298 · 2022: 305 · 2021: 286 · 2020: 312 · 2019: 279 · 2018: 236 · 2017: 210 · 2016: 123
- FWCI
- 116.87
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- PubMed Central (acceptedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- Radboud Repository (Radboud University) (submittedVersion)
- Funders
- National Institute on Aging (P01AG041122, R37AG013925)
- National Heart, Lung, and Blood Institute (R01HL111121)
- National Cancer Institute (R01CA166347, R01CA096985, P30CA015083)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Aging › Genetics, Aging, and Longevity in Model Organisms
- Health Sciences › Medicine › Geriatrics and Gerontology › Sirtuins and Resveratrol in Medicine
- Keywords
- cellular senescence, p16INK4a, senolytics, healthspan, aging, senescent cell clearance, carcinogenesis, renal function, cardiac KATP channels, adipocytes, AP20187, CDKN2A
- MeSH terms
- Aging, Animals, Cell Separation, Cell Transformation, Neoplastic, Epithelial Cells, Female, Health, Kidney, Lipodystrophy, Longevity, Male, Myocardium, Organ Specificity, Stem Cells, Time Factors, Cellular Senescence, Apoptosis, Adipocytes, Cyclin-Dependent Kinase Inhibitor p16, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-09-29, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-09-29 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.